A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients
A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients
Recruiting · NCT07517250 · Registry updated 2026-06-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Skin and Connective Tissue Diseases, adult-onset Still disease, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, familial Mediterranean fever, hereditary disease, hereditary periodic fever syndrome, immune system disorder, juvenile idiopathic arthritis, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis, systemic-onset juvenile idiopathic arthritis | Recruiting | Not stated | 2026-06-09 | NCT07517250 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Novartis Pharmaceuticals | 432 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Novartis | Basel | Switzerland | 1 |